InvestorsHub Logo
Followers 14
Posts 603
Boards Moderated 0
Alias Born 12/27/2017

Re: loanranger post# 388608

Monday, 03/07/2022 2:05:25 PM

Monday, March 07, 2022 2:05:25 PM

Post# of 402726
Lol... whaaaaat?

1. Why on earth did it take SO long (months) to release this info?

2.

Progress in the Brilacidin antiviral program largely will be dependent upon obtaining government funding for additional clinical development and leveraging external research relationships. Going forward, our business focus will be to advance Brilacidin in other disease areas and to pursue new business opportunities through joint ventures and other investments.



To me, this sounds like B is dead. If it were SO insanely 'promising', then why would Leo be 'pursuing new business opportunities through JV's and other investments?

Literally years have gone by at this point, the shareholders have been diluted into oblivion, and there's zero revenue, partnerships or any outside interest going in any direction. Kevetrin is dead. Patents are expiring. Does nobody care about Leo and his mailbox and magic elixirs?

Change my mind...

Is this great news or what?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News